Mitsubishi Chemical Group has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a bid to focus on its key chemical businesses. The Japanese chemical company said ...

Japan's Mitsubishi Chemical said on Friday it will sell pharmaceutical unit Tanabe Mitsubishi Pharma to U.S. private equity firm Bain Capital in a deal worth 510 billion yen ($3.36 billion) as it ...

Brentwood, Tenn.-based Surgery Partners received a nonbinding acquisition proposal from Bain Capital Private Equity on Jan. 27, offering to buy all outstanding shares for $25.75 per share in cash.

All energy, oil and gas, and natural resources sector investments from 2015 forward are made through or alongside the Morgan Stanley Energy Partners (MSEP ... investors willing to forego liquidity and ...

As the global private equity industry took tentative steps toward recovery in 2024, Japan raced ahead. Read more here.

Bain Capital already owns nearly 40 percent of the Tennessee-based company’s stock. An analyst thinks other potential buyers ...

Check out who's buying and selling in this week's roundup of healthcare mergers, acquisitions and joint ventures.

Surgery Partners received a non-binding offer from Bain Capital to acquire the rest of the company, valued at $3.25 billion. Read more about the M&A activity.

Analyst Whit Mayo of Leerink Partners reiterated a Buy rating on Surgery Partners (SGRY – Research Report), with a price target of ...

Bain Capital proposes to take Surgery Partners private The cyberattack at UnitedHealth Group's tech unit last year affected the personal information of 190 million people, the health conglomerate ...

Surgery Partners has received an acquisition offer the could take the public company private. Boston-based Bain Capital Partners has made an offer to purchase all outstanding shares of the company for ...

As multiple media reported, Bain Capital has proposed acquiring all outstanding Surgery Partners shares not already owned by ...